Mifepristone
Active substance: mifepristone
TABLET · MIFEPRISTONE 200 mg/1
United StatesActive
Marketing holder: GenBioPro, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- MIFEPRISTONE · 200 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 29 |
|
| EU 1 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2cde-7b72-9c8a-29627fb00b76,01a120c3-5c75-745e-b83e-aea805a9a1ec,01a120c3-670b-7357-8a8a-61c69a91de32,01a120c3-9058-7399-9b9b-9ea0d0d34596,01a120c3-ce11-77c7-a39f-e0b1d33e011b;count=12 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-1472-7d50-b579-fe9aa8d1e24d,01a12095-24db-7757-b952-248f786b7f50,01a12098-70d6-75a0-aeca-4160af9f88bf,01a12099-f93d-7cb4-8044-5485e1a90e91,01a1209c-8cfe-7f5a-9b17-bd67d95260b8;count=5 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 43393-001
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 43393-001 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43393-001 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43393-001 · Verified 2026-10-09 · open in source